English
French
German
Italian
Russian
Spanish
Democratic-led U.S. states challenge restrictions on abortion pill
Democratic-led U.S. states challenge restrictions on abortion pill By Reuters
Breaking News
‘;
Stock Markets 1 hour ago (Feb 24, 2023 01:46PM ET)
(C) Reuters. FILE PHOTO: A pack of Mifeprex pills, used to terminate early pregnancies, is displayed in this picture illustration taken May 11, 2022. REUTERS/Caitlin Ochs/Illustration
By Brendan Pierson
(Reuters) – Twelve Democratic-led states have sued the U.S. Food and Drug Administration to challenge certain restrictions imposed on the distribution of the abortion pill mifepristone, saying those limits are not supported by evidence.
The lawsuit, led by Washington state and Oregon, was filed on Thursday in federal court in Yakima, Washington. A separate lawsuit by anti-abortion activists seeks to end access to the drug altogether.
Mifepristone, in combination with the drug misoprostol, is approved by the FDA for medication abortion in the first 10 weeks of pregnancy. Medication abortion accounts for more than half of U.S. abortions.
The new lawsuit challenges restrictions on mifepristone including requirements that doctors who prescribe it, and pharmacies that dispense it, obtain a special certification.
The FDA did not immediately respond to a request for comment.
Medication abortion has drawn increasing attention since the U.S. Supreme Court last year reversed its landmark 1973 Roe v. Wade ruling that had legalized abortion nationwide. The ruling enabled more than a dozen Republican-led states to adopt new abortion bans.
Democratic-led U.S. states challenge restrictions on abortion pill
Terms And Conditions
Privacy Policy
Risk Warning
(C) 2007-2023 Fusion Media Limited. All Rights Reserved.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
